- Home
- SLNO vs RDN Comparison
SLNO vs RDN Comparison
Compare SLNO & RDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- RDN
- Stock Information
- Founded
- SLNO 1999
- RDN 1977
- Country
- SLNO United States
- RDN United States
- Employees
- SLNO N/A
- RDN N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RDN Property-Casualty Insurers
- Sector
- SLNO Health Care
- RDN Finance
- Exchange
- SLNO Nasdaq
- RDN Nasdaq
- Market Cap
- SLNO 3.8B
- RDN 4.8B
- IPO Year
- SLNO 2014
- RDN 1992
- Fundamental
- Price
- SLNO $84.87
- RDN $33.57
- Analyst Decision
- SLNO Strong Buy
- RDN Hold
- Analyst Count
- SLNO 9
- RDN 7
- Target Price
- SLNO $105.11
- RDN $36.86
- AVG Volume (30 Days)
- SLNO 1.4M
- RDN 1.1M
- Earning Date
- SLNO 08-06-2025
- RDN 07-30-2025
- Dividend Yield
- SLNO N/A
- RDN 3.06%
- EPS Growth
- SLNO N/A
- RDN 4.01
- EPS
- SLNO N/A
- RDN 3.92
- Revenue
- SLNO N/A
- RDN $1,288,979,000.00
- Revenue This Year
- SLNO N/A
- RDN N/A
- Revenue Next Year
- SLNO $506.77
- RDN $2.30
- P/E Ratio
- SLNO N/A
- RDN $8.52
- Revenue Growth
- SLNO N/A
- RDN 3.11
- 52 Week Low
- SLNO $41.50
- RDN $29.32
- 52 Week High
- SLNO $90.32
- RDN $37.86
- Technical
- Relative Strength Index (RSI)
- SLNO 51.86
- RDN 42.23
- Support Level
- SLNO $83.53
- RDN $33.27
- Resistance Level
- SLNO $89.12
- RDN $34.15
- Average True Range (ATR)
- SLNO 2.58
- RDN 0.52
- MACD
- SLNO -0.44
- RDN -0.09
- Stochastic Oscillator
- SLNO 49.70
- RDN 24.19
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About RDN Radian Group Inc.
Radian Group Inc is engaged in mortgage and real estate services. It provides both credit-related mortgage insurance coverage and other products and services across the residential real estate and mortgage finance industries. It has one business segment Mortgage Insurance. The Mortgage Insurance segment aggregates, manages, and distributes U.S. mortgage credit risk for the benefit of mortgage lending institutions and mortgage credit investors, through private mortgage insurance on residential first-lien mortgage loans, and also offers other credit risk management solutions, including contract underwriting, to customers. It also provides other mortgage and real estate products and services through Mortgage Conduit, Title, Real Estate Services, and Real Estate Technology businesses.